Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Rule 8.4 Disclosure

10 Mar 2009 11:20

RNS Number : 6127O
W.H. Ireland Group PLC
10 March 2009
 



10 March 2009

WH Ireland Group PLC ("WH Ireland")

Rule 8.4 Disclosure

As referred to in the announcement released by WH Ireland and Blue Oar PLC ("Blue Oar") on 2 March 2009, the irrevocable commitment received by WH Ireland from Evolve Capital PLC ("Evolve") (the "Evolve Undertaking") to vote in favour of (or accept) the possible offer by WH Ireland for Blue Oar (the "Possible Offer") in respect of Evolve's entire holding of Blue Oar shares (representing approximately 64.9 per cent. of the existing issued share capital of Blue Oar) ceased to be binding if, inter alia, an announcement of a firm intention to make an offer under Rule 2.5 of the City Code was not made by 12 noon on 9 March 2009.

WH Ireland and Blue Oar further announced on 9 March 2009 that discussions were well advanced and ongoing between the parties and that a further announcement would be made in due course.

As the Evolve Undertaking has now ceased to be binding, WH Ireland announces it no longer has a disclosable interest in the securities of Blue Oar under the provisions of Rule 8.4 of the City Code.

Enquiries:

WH Ireland

Richard Ford

Tel: 020 7220 0475

Oriel Securities Ltd

Tom Durie

Jonathan Walker

Tel: 020 7710 7600

Biddicks (Financial PR to WH Ireland)

Zoe Biddick

Tel: 020 7448 1000

Dealing Disclosure Requirements

The disclosure requirements are set out in more detail in Rule 8 of the Code. In particular, under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 'interested' (directly or indirectly) in one per cent. or more of any class of 'relevant securities' of Blue Oar or WH Ireland, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the offer period otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Blue Oar or WH Ireland, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Blue Oar or WH Ireland by WH Ireland or Blue Oar, or by any of their respective 'associates' (within the meaning of the Code), must also be disclosed by no later than 12.00 p.m. (London time) on the Business Day following the date of the relevant transaction.

A disclosure table giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8 of the Code, you should consult the Panel.

If you are in any doubt as to the application of Rule 8 to you, please contact an independent financial adviser authorised under the Financial Services and Markets Act 2000, consult the Panel's website at www.thetakeoverpanel.org.uk or contact the Panel on telephone number +44 (020) 7638 0129; fax: +44 (020) 7236 7013.

This Announcement does not constitute, or form part of, an offer or invitation to purchase any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPMGGMFMGVGLZM
Date   Source Headline
17th Nov 202512:58 pmRNSForm 8.3 - W.H. Ireland Group PLC
14th Nov 202510:13 amRNSForm 8 (DD)
13th Nov 20259:39 amRNSForm 8.3 - WH Ireland Group plc
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
5th Nov 20257:00 amRNSDirectorate Change
29th Oct 20257:00 amRNSDeferred Consideration re Capital Markets Division
27th Oct 20252:51 pmRNSResult of GM
27th Oct 20257:00 amRNSDirectorate Change
20th Oct 20251:49 pmRNSAdjournment of GM
16th Oct 20259:24 amRNSHolding(s) in Company
16th Oct 20259:23 amRNSHolding(s) in Company
9th Oct 20253:07 pmRNSResult of General Meeting
8th Oct 202510:21 amRNSResponse to Press Speculation
30th Sep 20253:23 pmRNSResult of AGM
26th Sep 20254:14 pmRNSFinal Results, Notice of GM and Annual Report
22nd Sep 20257:26 amRNSConditional disposal of Wealth Management Business
5th Sep 20257:00 amRNSNotice of AGM
10th Feb 20257:00 amRNSHenley Office
17th Dec 20241:17 pmRNSHolding(s) in Company
13th Dec 20247:04 amRNSInterim Results
17th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSNominated Adviser Status
30th Sep 20244:08 pmRNSResult of AGM
10th Sep 20249:51 amRNSHolding(s) in Company
30th Aug 202412:00 pmRNSNotice of AGM and Publication of Annual Report
22nd Aug 20245:46 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSCompletion of Sale of the Capital Markets Division
27th Jun 20246:19 pmRNSHolding(s) in Company
27th Jun 20246:17 pmRNSHolding(s) in Company
26th Jun 202410:26 amRNSConfirmation of Chair Appointment
21st Jun 20248:09 amRNSDirector Notification
3rd Jun 20247:00 amRNSSale of Capital Markets Division & Trading Update
20th May 202411:14 amRNSResponse to Press Speculation
27th Dec 20237:00 amRNSInterim Results for Six Months ended 30 Sep 2023
16th Nov 20237:00 amRNSBoard Changes
24th Oct 20232:07 pmRNSResult of AGM
27th Sep 20237:00 amRNSFinal Results and Notice of AGM
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 202310:08 amRNSHolding(s) in Company
22nd Aug 202310:07 amRNSHolding(s) in Company
21st Aug 20239:26 amRNSHolding(s) in Company
18th Aug 202311:06 amRNSHolding(s) in Company
17th Aug 20235:14 pmRNSHolding(s) in Company
17th Aug 20234:09 pmRNSHolding(s) in Company
17th Aug 20239:16 amRNSHolding(s) in Company
16th Aug 20232:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.